0.734
price up icon3.38%   0.024
 
loading
前日終値:
$0.71
開ける:
$0.7261
24時間の取引高:
46,996
Relative Volume:
0.30
時価総額:
$28.64M
収益:
$135.87M
当期純損益:
$72.20M
株価収益率:
0.5169
EPS:
1.42
ネットキャッシュフロー:
$45.09M
1週間 パフォーマンス:
-3.42%
1か月 パフォーマンス:
+0.55%
6か月 パフォーマンス:
-32.04%
1年 パフォーマンス:
-66.94%
1日の値動き範囲:
Value
$0.726
$0.738
1週間の範囲:
Value
$0.7008
$0.7726
52週間の値動き範囲:
Value
$0.66
$2.26

Scynexis Inc Stock (SCYX) Company Profile

Name
名前
Scynexis Inc
Name
セクター
Healthcare (1163)
Name
電話
201-884-5485
Name
住所
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Name
職員
29
Name
Twitter
@scynexis
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
SCYX's Discussions on Twitter

SCYX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
SCYX
Scynexis Inc
0.734 27.70M 135.87M 72.20M 45.09M 1.42
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.45 67.31B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.74 45.95B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.75 43.35B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.58 18.68B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
305.61 13.44B 2.99B 1.21B 1.13B 25.06

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-01-22 開始されました Guggenheim Buy
2021-01-06 開始されました Cantor Fitzgerald Overweight
2018-07-11 アップグレード Needham Hold → Buy
2018-06-27 開始されました Maxim Group Buy
2017-10-24 開始されました Guggenheim Buy
2017-07-10 開始されました ROTH Capital Buy
2017-05-09 ダウングレード Needham Buy → Hold
2017-03-03 繰り返されました RBC Capital Mkts Outperform
2016-10-20 開始されました H.C. Wainwright Buy
2016-10-07 アップグレード WBB Securities Buy → Strong Buy
2016-10-03 再開されました Brean Capital Buy
2016-08-17 開始されました Guggenheim Buy
2016-08-09 繰り返されました Needham Buy
2016-08-09 アップグレード WBB Securities Speculative Buy → Buy
2016-03-28 開始されました Brean Capital Buy
2015-12-29 開始されました WBB Securities Speculative Buy
2015-11-16 繰り返されました RBC Capital Mkts Outperform
2015-06-10 開始されました Needham Buy
2014-05-29 開始されました Canaccord Genuity Buy
2014-05-29 開始されました RBC Capital Mkts Outperform
すべてを表示

Scynexis Inc (SCYX) 最新ニュース

pulisher
Jul 23, 2025

Is SCYNEXIS Inc. a good long term investmentFree Investment Risk Control - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives SCYNEXIS Inc. stock priceUnmatched market performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about SCYNEXIS Inc. stockUnstoppable profit momentum - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

SCYNEXIS Inc. Stock Analysis and ForecastFast-track wealth growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 19, 2025

Is ATH.PRA a good long term investmentSkyrocketing returns - Jammu Links News

Jul 19, 2025
pulisher
Jul 16, 2025

What makes SCYNEXIS Inc. stock price move sharplyTop Analyst Picks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why SCYNEXIS Inc. stock attracts strong analyst attentionGrowth Stock Monitor - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How SCYNEXIS Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Scynexis Inc (SCYX) Stock: A Year of Highs and Lows in the Market - investchronicle.com

Jul 15, 2025
pulisher
Jul 02, 2025

SCYNEXIS Holds Annual Meeting, Re-elects Directors - The Globe and Mail

Jul 02, 2025
pulisher
Jun 26, 2025

SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price - TipRanks

Jun 26, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 15, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Buys New Holdings in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

Bright Minds Biosciences (NASDAQ:DRUG) & SCYNEXIS (NASDAQ:SCYX) Head-To-Head Survey - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Biosergen taps antifungal expert as board member - Biostock

Jun 05, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Has $186,000 Stake in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

Jun 03, 2025
pulisher
May 29, 2025

Scynexis resumes dosing in Phase III MARIO study after lengthy delay - MSN

May 29, 2025
pulisher
May 29, 2025

SCYNEXIS resumes Phase 3 antifungal study after FDA lift By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA Hold - Insider Monkey

May 29, 2025
pulisher
May 28, 2025

Scynexis resumes patient dosing in Phase 3 MARIO study - TipRanks

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing In Phase 3 MARIO Study - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX St - GuruFocus

May 28, 2025
pulisher
May 28, 2025

GSK Involved in SCYNEXIS's Phase 3 Study Milestone Dispute | GSK Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS resumes Phase 3 antifungal study after FDA lift - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study - The Manila Times

May 28, 2025
pulisher
May 28, 2025

SCYNEXIS Restarts Critical Phase 3 Trial for Life-Threatening Infection, Faces $30M GSK Payment Battle - Stock Titan

May 28, 2025
pulisher
May 19, 2025

SCYNEXIS Faces Challenges Amidst Antifungal Developments - TipRanks

May 19, 2025

Scynexis Inc (SCYX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.31
price up icon 1.34%
$15.02
price up icon 0.60%
$9.37
price up icon 1.41%
drug_manufacturers_specialty_generic RDY
$14.60
price up icon 1.32%
$133.66
price up icon 0.69%
$305.61
price up icon 2.59%
大文字化:     |  ボリューム (24 時間):